Skip to main content
. 2010 Sep 16;14(10):1521–1528. doi: 10.1007/s11605-010-1340-6

Table 2.

Frequency of tetranucleotide marker mutations in rectal cancers

Loci MYCL1 D20S85 D8S321 D20S82 D9S242
All rectal tumors
# Times mutated (N = 147) 35 (25%) 9 (8%) 43 (30%) 43 (30%) 35 (24%)
EMAST tumors
# Times mutated (N = 49) 23 (47%) 5 (10%) 30 (61%) 32 (65%) 24 (49%)